Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy? (Q53817138)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy?	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

title

Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

main subject

pancreaticoduodenectomy

0 references

contraindication

1 reference

based on heuristic

inferred from title

author name string

O Turrini

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

C M Schmidt

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

J Moreno

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

P Parikh

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

J M Matos

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

M G House

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

N J Zyromski

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

A Nakeeb

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

H A Pitt

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

K D Lillemoe

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

publication date

21 May 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

published in

Journal of Gastrointestinal Surgery

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

page(s)

1791-1797

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

cites work

Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-alpha in pancreatic and periampullary cancer: results of a feasibility study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11605-009-0916-5

retrieved

21 January 2018

CA 19-9 in Pancreatic Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical usefulness of CA-19-9 in pancreatic carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perioperative management of pancreatic cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic pancreatic cancer 2008: is the glass less empty?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current adjuvant and targeted therapies for pancreatic adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting resectability of periampullary cancer with three-dimensional computed tomography

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic adenocarcinoma: the actual 5-year survivors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 19-9 velocity predicts disease-free survival and overall survival after pancreatectomy of curative intent

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19459018

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11605-009-0916-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

PubMed publication ID

19459018

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19459018

retrieved

20 May 2018

reference URL

http://europepmc.org/abstract/MED/19459018

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53817138&oldid=2212300634"